These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26742077)

  • 1. Cancer Stem Cell Plasticity Drives Therapeutic Resistance.
    Doherty MR; Smigiel JM; Junk DJ; Jackson MW
    Cancers (Basel); 2016 Jan; 8(1):. PubMed ID: 26742077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy.
    Zheng X; Yu C; Xu M
    Front Oncol; 2021; 11():678333. PubMed ID: 34262865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
    Jayachandran A; Dhungel B; Steel JC
    J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Stem Cell Plasticity - A Deadly Deal.
    Thankamony AP; Saxena K; Murali R; Jolly MK; Nair R
    Front Mol Biosci; 2020; 7():79. PubMed ID: 32426371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Plasticity-Targeted Therapy in Head and Neck Cancers.
    Shang W; Zhang Q; Huang Y; Shanti R; Alawi F; Le A; Jiang C
    J Dent Res; 2018 Jun; 97(6):654-664. PubMed ID: 29486673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
    Garg M
    Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
    Garg M
    Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.
    Najafi M; Mortezaee K; Ahadi R
    Life Sci; 2019 Aug; 231():116520. PubMed ID: 31158379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism-based computational model to capture the interconnections among epithelial-mesenchymal transition, cancer stem cells and Notch-Jagged signaling.
    Bocci F; Jolly MK; George JT; Levine H; Onuchic JN
    Oncotarget; 2018 Jul; 9(52):29906-29920. PubMed ID: 30042822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.
    Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH
    Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.
    Chanmee T; Ontong P; Kimata K; Itano N
    Front Oncol; 2015; 5():180. PubMed ID: 26322272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Stem Cell Metabolism and Potential Therapeutic Targets.
    Snyder V; Reed-Newman TC; Arnold L; Thomas SM; Anant S
    Front Oncol; 2018; 8():203. PubMed ID: 29922594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial plasticity and cancer stem cells: Major mechanisms of cancer pathogenesis and therapy resistance.
    Garg M
    World J Stem Cells; 2017 Aug; 9(8):118-126. PubMed ID: 28928908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular plasticity and metastasis in breast cancer: a pre- and post-malignant problem.
    Smigiel JM; Taylor SE; Bryson BL; Tamagno I; Polak K; Jackson MW
    J Cancer Metastasis Treat; 2019; 5():. PubMed ID: 32355893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity.
    Yang XG; Zhu LC; Wang YJ; Li YY; Wang D
    Front Oncol; 2019; 9():887. PubMed ID: 31552191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.